Datatrak International, Inc. Discusses Potential of Its eClinicial and Predictive Analytics Platform with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - September 22, 2021) - The Stock Day Podcast welcomed Datatrak International, Inc. (OTC Pink: DTRK) ("the Company"), a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry. CEO of the Company, Jim Bob Ward, and Chairman, Alex Tabatabai, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about the Company's background and current projects. "We got involved with Datatrak about five years ago," said Tabatabai. "We saw a good opportunity but a company that needed to change its direction," he added. "For the last five years we have been focused on expanding the product offerings, which is now complete."
"What makes Datatrak's Enterprise Cloud platform so special?" asked Jolly. "A recent article in the US Library of Medicine shows that decentralized trials, without an eClinical platform, is estimated to double the cost of data management without any benefit of site and lab data," explained Ward. "This marriage of decentralized trials through hybrid models within eClinical platforms is driving a lot of attention to us; there is a lot of excitement in the marketplace."
"What makes your company a compelling story?" asked Jolly. "What drew us initially to the stock is that it is at the crossroads of two huge trends," shared Tabatabai, adding that these include life sciences and the increasing demand for digital solutions.
"What does the future look like for Datatrak?" asked Jolly. "I think in terms of our industry, this is just the beginning of a lot more attention and money being dedicated to it," said Tabatabai, before elaborating on the Company's investment potential given their current low market cap. "We are also in a position where we are having a huge technological development in life sciences," he added. "The COVID vaccines have been a major pivot for that, so we think that will lead to a lot more drug development, which will mean more treatments and cures for things that have troubled humanity, more people will get access to clinical trials, and it should become more affordable."
"How do your solutions make money?" asked Jolly. "We empower Contract Research Organizations as channel partners and value-added resellers to extend our software through their professional services," said Ward. "We don't have to design the trial and test it and implement it for you; we have global resellers who can do that for you with any language or skill set," he explained. "We're now looking to the future of clinical R&D with business intelligence using artificial intelligence and machine learning for predictive analytics from the data we capture," said Ward. "Datatrak is announcing the introduction of Business Intelligence within our platform later this year."
To hear Jim Bob Ward's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7946610-datatrak-international-inc-discusses-potential-of-its-eclinicial-and-predictive-analytics-platf.
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About Datatrak International, Inc.
Datatrak International, Inc. is a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry. Datatrak's unified eClinical solutions and related services help improve cost and time efficiencies for the clinical trials industry. Datatrak built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via Datatrak's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The Datatrak Enterprise Cloud software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. Datatrak is located in Cleveland, Ohio, and College Station, Texas. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. All statements that address operating performance, events or developments that management anticipates will occur in the future, including statements related to future revenue, profits, the impact of COVID-19, expenses, cost reductions, cash management alternatives and working capital requirements, release or success of new products, market share, strategic alternatives, raising additional funds, income and earnings per share or statements expressing general opinion about future results, are forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward-looking statements, please see the Company's report filed with the OTC Markets on March 26, 2021 announcing its results for the full-year period ended December 31, 2020 and subsequent filings with the OTC Markets. Many such factors have been, and may further be, exacerbated by the COVID-19 pandemic. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
Employment Opportunities: Laura.Stuebbe@datatrak.com
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.
Stock Day Media